Peregrine Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-459,716
| Closed | -$6.68M | – | 345 |
|
|
2021
Q2 | $6.68M | Sell |
459,716
-24,490
| -5% | -$356K | 0.12% | 253 |
|
|
2021
Q1 | $9.88M | Sell |
484,206
-67,624
| -12% | -$1.38M | 0.18% | 233 |
|
|
2020
Q4 | $9.81M | Buy |
551,830
+139,236
| +34% | +$2.47M | 0.19% | 233 |
|
|
2020
Q3 | $6.1M | Sell |
412,594
-39,361
| -9% | -$582K | 0.16% | 203 |
|
|
2020
Q2 | $9.49M | Buy |
+451,955
| New | +$9.49M | 0.27% | 134 |
|